Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ASLAN Pharmaceuticals Limited (ASLN)

1.9   0 (0%) 09-29 10:13
Open: 1.88 Pre. Close: 1.9
High: 1.9 Low: 1.88
Volume: 13,640 Market Cap: 72M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.922 - 1.929 1.929 - 1.935
Low: 1.762 - 1.77 1.77 - 1.777
Close: 1.887 - 1.9 1.9 - 1.912

Technical analysis

as of: 2020-09-28 4:29:58 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.24     One year: 2.62
Support: Support1: 1.51    Support2: 1.26
Resistance: Resistance1: 1.92    Resistance2: 2.24
Pivot: 1.60
Moving Average: MA(5): 1.82     MA(20): 1.57
MA(100): 1.74     MA(250): 1.76
MACD: MACD(12,26): 0.06     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 88.75     %D(3): 89.56
RSI: RSI(14): 67.22
52-week: High: 8.18  Low: 0.35  Change(%): 14.5
Average Vol(K): 3-Month: 8081  10-Days: 9688

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ASLN has closed below upper band by 6.1%. Bollinger Bands are 121.5% wider than normal. The large width of the bands suggest high volatility as compared to ASLN's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Fri, 25 Sep 2020
ASLAN Pharmaceuticals : 2020 Second Extraordinary General Meeting Minutes -

Thu, 24 Sep 2020
What is the Market's View on Aslan Pharmaceuticals Ltd (ASLN) Stock's Price and Volume Trends - InvestorsObserver

Mon, 21 Sep 2020
ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study - Yahoo Finance

Thu, 10 Sep 2020
ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference - Yahoo Finance

Wed, 02 Sep 2020
What is the Forecast Price for Aslan Pharmaceuticals Ltd (ASLN) Stock? - InvestorsObserver

Mon, 24 Aug 2020
ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38
Shares Float (M) 37
% Held by Insiders
% Held by Institutions 8.68
Shares Short (K) 142
Shares Short P. Month (K) 108

Stock Financials

EPS -1.240
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.230
Profit Margin
Operating Margin
Return on Assets (ttm) -41.6
Return on Equity (ttm) -769.8
Qtrly Rev. Growth
Gross Profit (p.s.) 2.101
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -1.53
PEG Ratio
Price to Book value -8.26
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.